Estrella Immunopharma Warrants ESLAW Hold Steady at 013 Key Levels in Focus SpaceX IPO Potential Early Investors Could See Significant Returns Market Speculation Suggests OKLO Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued PreRevenue Development Time Magazine Examines Paths to Revitalize the Global Trade Architecture